The settlement is likely to boost Purdue’s effort to move past claims it helped spark a public-health crisis over opioids with its marketing of OxyContin. Photo: TNS
OxyContin maker Purdue Pharma to plead guilty, pay US$8.3 billion over opioids
- Company’s marketing of addictive painkiller allegedly helped spark opioid crisis, which led to more than 200,000 US overdose deaths
- Purdue, owned by members of billionaire Sackler family, still faces thousands of claims by local and state officials
The settlement is likely to boost Purdue’s effort to move past claims it helped spark a public-health crisis over opioids with its marketing of OxyContin. Photo: TNS
